| 12312352 |
Use of a DPP-4 inhibitor in SIRS and/or sepsis |
Thomas KLEIN, Andreas DAIBER, Klaus Dugi, Thomas MUENZEL |
2025-05-27 |
| 12171767 |
Uses of DPP IV inhibitors |
Klaus Dugi, Frank Himmelsbach |
2024-12-24 |
| 12115179 |
Pharmaceutical composition, methods for treating and uses thereof |
Peter Eickelmann, Leo John SEMAN, Leo Thomas, Uli Christian BROEDL, Rolf GREMPLER |
2024-10-15 |
| 11911388 |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug |
Eva Ulrike GRAEFE-MODY, Thomas KLEIN, Hans-Juergen WOERLE |
2024-02-27 |
| 11911387 |
Vasoprotective and cardioprotective antidiabetic therapy |
Thomas KLEIN, Andreas DAIBER, Odd-Erik JOHANSEN, Sanjaykumar PATEL, Hans-Juergen WOERLE |
2024-02-27 |
| 11291668 |
Uses of DPP IV inhibitors |
Klaus Dugi, Frank Himmelsbach |
2022-04-05 |
| 10406172 |
Pharmaceutical composition, methods for treating and uses thereof |
Peter Eickelmann, Leo John SEMAN, Leo Thomas, Uli Christian BROEDL, Rolf GREMPLER |
2019-09-10 |
| 10195203 |
Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome |
Thomas KLEIN, Maximilian von EYNATTEN |
2019-02-05 |
| 10092571 |
Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin |
Klaus Dugi, Eva Ulrike GRAEFE-MODY, Hans-Juergen WOERLE, Heike ZIMDAHL-GELLING |
2018-10-09 |
| 10080754 |
Uses of DPP IV inhibitors |
Klaus Dugi, Frank Himmelsbach |
2018-09-25 |
| 10004747 |
Combination therapy |
Thomas KLEIN, Rolf GREMPLER |
2018-06-26 |
| 9713618 |
Method for modifying food intake and regulating food preference with a DPP-4 inhibitor |
Thomas KLEIN |
2017-07-25 |
| 9603851 |
Combination therapy |
Thomas KLEIN, Rolf GREMPLER |
2017-03-28 |
| 9556175 |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions |
Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Roland Maier, Ralf Lotz +1 more |
2017-01-31 |
| 9526730 |
Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome |
Thomas KLEIN, Maximilian von EYNATTEN, Berthold Hocher, Yuliya SHARKOVSKA |
2016-12-27 |
| 9457029 |
Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin |
Klaus Dugi, Eva Ulrike GRAEFE-MODY, Hans-Juergen WOERLE, Heike ZIMDAHL-GELLING |
2016-10-04 |
| 9321791 |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Roland Maier, Ralf Lotz +1 more |
2016-04-26 |
| 9186392 |
Combination therapy |
Thomas KLEIN, Rolf GREMPLER |
2015-11-17 |
| 9173859 |
Uses of DPP IV inhibitors |
Klaus Dugi, Frank Himmelsbach |
2015-11-03 |
| 9149478 |
Diabetes therapy |
Thomas KLEIN, Leo Thomas |
2015-10-06 |
| 9034883 |
Vasoprotective and cardioprotective antidiabetic therapy |
Thomas KLEIN, Andreas DAIBER, Odd-Eric JOHANSEN, Sanjaykumar PATEL, Hans-Juergen WOERLE |
2015-05-19 |
| 8673927 |
Uses of DPP-IV inhibitors |
Klaus Dugi, Frank Himmelsbach |
2014-03-18 |
| 8664232 |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Roland Maier, Ralf Lotz +1 more |
2014-03-04 |
| 8551957 |
Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate |
Klaus Dugi, Leo Thomas, Frank Himmelsbach |
2013-10-08 |
| 8513264 |
Combination therapy for the treatment of diabetes and related conditions |
Peter Eickelmann, Gerd LUIPPOLD, Leo Thomas |
2013-08-20 |